Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japa...
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
RAS/BRAF
mutations are the most remarkable oncogenic driver mutations in colorectal cancer (CRC) and play an important role in treatment selection. No data are available regarding the clinical and prognostic features of patients with detailed RAS/BRAF
-mutant metastatic CRC (mCRC) in Japan.
A total of 152 chemotherapy-naïve patients with m...
Alternative Titles
Full title
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_daed111adc22406db03938d47afb31d4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_daed111adc22406db03938d47afb31d4
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-021-08271-z
